Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Nathalie Devos"'
Autor:
Sonia Schoonbroodt, Jean-Laurent Ichanté, Sophie Boffé, Nathalie Devos, Jeanne-Marie Devaster, Laura Taddei, Simona Rondini, Ashwani Kumar Arora, Thierry Pascal, Ludovic Malvaux
Publikováno v:
Frontiers in Microbiology, Vol 13 (2023)
IntroductionWe compared the performance of real-time PCR with culture-based methods for identifying bacteria in sputum samples from patients with chronic obstructive pulmonary disease (COPD) in three studies.MethodsThis was an exploratory analysis of
Externí odkaz:
https://doaj.org/article/204774b2a91347fe9db3321b4e8e4600
Autor:
Steven Van Vooren, James Grayson, Marc Van Ranst, Elisabeth Dequeker, Lies Laenen, Reile Janssen, Laurent Gillet, Fabrice Bureau, Wouter Coppieters, Nathalie Devos, Benjamin Hengchen, Pierre Wattiau, Sibylle Méhauden, Yvan Verlinden, Kurt Van Baelen, Theresa Pattery, Jean-Pierre Valentin, Kris Janssen, Martine Geraerts, John Smeraglia, Jan Hellemans, Pieter Wytynck, Pieter Mestdagh, Nienke Besbrugge, René Höfer, Friedel Nollet, Jo Vandesompele, Pieter De Smet, John Lebon, Emmanuel Vandewynckele, Steven Verstrepen, Wouter Uten, Arnaud Capron, Hugues Malonne, Jeroen Poels, Emmanuel André
Publikováno v:
Life, Vol 12, Iss 2, p 159 (2022)
We present our approach to rapidly establishing a standardized, multi-site, nation-wide COVID-19 screening program in Belgium. Under auspices of a federal government Task Force responsible for upscaling the country’s testing capacity, we were able
Externí odkaz:
https://doaj.org/article/7a200fc5f8174981a15e82afbd3ce110
Autor:
Jan Poolman, Philippe Denoël, Nathalie Devos, Christiane Feron, Karine Goraj, Patricia Momin, Christine Tans, Vincent Weynants
Publikováno v:
VacciMonitor, Vol 18, Iss 2, Pp 66-68 (2009)
With the development of conjugate vaccines, Neisseria meningitidis serogroup B (MenB) will remain the major cause of meningitis, as it is not covered by vaccination. In order to develop a vaccine able to confer a broad cross-protection against invasi
Externí odkaz:
https://doaj.org/article/f1729bbb5cf94cbbb9b9b3d2f669a40a
Autor:
Michiel Stork, Jan Grijpstra, Martine P Bos, Carmen Mañas Torres, Nathalie Devos, Jan T Poolman, Walter J Chazin, Jan Tommassen
Publikováno v:
PLoS Pathogens, Vol 9, Iss 10, p e1003733 (2013)
The outer membrane of Gram-negative bacteria functions as a permeability barrier that protects these bacteria against harmful compounds in the environment. Most nutrients pass the outer membrane by passive diffusion via pore-forming proteins known as
Externí odkaz:
https://doaj.org/article/0300639d643b4513ad6b008b8f1e66b4
Autor:
Danilo Donnarumma, Fabiola Giusti, Carine Ysebaert, Philippe Hermand, Nathalie Devos, Ilaria Ferlenghi, Immaculada Margarit, Silvia Rossi Paccani, Maria Scarselli, Nathalie Norais
Publikováno v:
Vaccine. 40:6520-6527
Moraxella catarrhalis is an important and common respiratory pathogen that can cause Otitis Media, Community Acquired Pneumonia, and has been associated with an increased risk of exacerbations in chronic obstructive pulmonary disease in adults, leadi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e6f48fb670f8b9ef09b36c69bd91a1
https://doi.org/10.1016/j.vaccine.2022.09.048
https://doi.org/10.1016/j.vaccine.2022.09.048
Autor:
Cindy Castado, Christiane Feron, Vincent Weynants, Emmanuel Di Paolo, Marie-Cécile Mortier, Normand Blais, Stephane Rioux, Carine Ysebaert, Philippe Hermand, Nathalie Devos
Publikováno v:
Vaccine. 39:5641-5649
Moraxella catarrhalis (Mcat) is a key pathogen associated with exacerbations of chronic obstructive pulmonary disease (COPD) in adults and playing a significant role in otitis media in children. A vaccine would help to reduce the morbidity and mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee4737ec87feee54571e7bc5f9cb83c
https://doi.org/10.1016/j.vaccine.2021.08.002
https://doi.org/10.1016/j.vaccine.2021.08.002
Autor:
Lucio, Malvisi, Aparna, Yarraguntla, Marie-Cécile, Mortier, Karen, Osman, David W, Cleary, Béatrice, Sente, Thierry G, Pascal, Vincent, Weynants, Stuart C, Clarke, Laura, Taddei, Tom M A, Wilkinson, Jeanne-Marie, Devaster, Nathalie, Devos, S A, Wootton
Publikováno v:
Infectious diseases (London, England). 54(11)
BACKGROUND: Bacterial infections are associated with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), but the mechanism is incompletely understood.METHOD: In a COPD observational study (NCT01360398), sputum samples were collecte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a18c88d111d1cd4087535b47d3748d
https://pubmed.ncbi.nlm.nih.gov/35794793
https://pubmed.ncbi.nlm.nih.gov/35794793
Autor:
Stuart C. Clarke, Jeanne-Marie Devaster, Nathalie Devos, Tom Wilkinson, Karen L Osman, Christopher H. Woelk, Marie-Cécile Mortier, Thierry G. Pascal, David W. Cleary, Johanna M.C. Jefferies
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
H. haemolyticus is often misidentified as NTHi due to their close phylogenetic relationship. Differentiating between the two is important for correct identification and appropriate treatment of infective organism and to ensure any role of H. haemolyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9a13bb23a4b7e4beb4ed3fac2200713
https://eprints.soton.ac.uk/425373/
https://eprints.soton.ac.uk/425373/
Autor:
Myron Christodoulides, Nathalie Devos, Mélanie Gilbert, Vincent Weynants, John E. Heckels, Magdalena K. Bielecka, Miao-Chiu Hung
Publikováno v:
Infection and Immunity. 83:730-742
A recombinant macrophage infectivity potentiator (rMIP) protein of Neisseria meningitidis induces significant serum bactericidal antibody production in mice and is a candidate meningococcal vaccine antigen. However, bioinformatics analysis of MIP sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::303ccadd57db5366bd9abe606ceb895b
https://doi.org/10.1128/iai.01815-14
https://doi.org/10.1128/iai.01815-14
Autor:
Mark R. Alderson, Kurt Dobbelaere, Magali Traskine, Ezra O. Ogundare, Yauba Saidu, Brian Greenwood, Isatou Drammeh, Abdoulie Bojang, Sonia Schoonbroodt, Kristien Swinnen, Archibald Worwui, Beate Kampmann, Olumuyiwa Owolabi, Vincent Verlant, Martin Antonio, Nathalie Devos, Fatima Ceesay, Sheikh Jarju, Martin O. C. Ota, Ebenezer Foster-Nyarko, Dorota Borys, Aderonke Odutola, Olubukola T. Idoko, Patrick K. Owiafe
Background Conserved pneumococcal proteins are potential candidates for inclusion in vaccines against pneumococcal diseases. In the first part of a two-part study, an investigational vaccine (PHiD-CV/dPly/PhtD-30) containing 10 pneumococcal serotype-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd61e9fe0b86d96228263290b2f67972